PRPH - ProPhase Labs, Inc.
0.3626
-0.085 -23.414%
Share volume: 5,493,740
Last Updated: 01-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$0.45
-0.08
-0.19%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-14-2024 | 11-13-2024 | 05-20-2025 | 08-13-2025 | 11-19-2025 | |
| Assets | |||||||
| Total Assets | 90.032 M | 93.678 M | 91.808 M | 50.111 M | 42.041 M | 65.702 M | |
| Current Assets | 45.045 M | 44.143 M | 42.235 M | 24.770 M | 24.571 M | 7.773 M | |
| Inventories | 3.758 M | 3.867 M | 3.966 M | 1.145 M | 830.000 K | 266.000 K | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 58.000 K | 1.000 K | 2.000 K | 0.000 | 2.000 K | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.175 M | 1.780 M | 501.000 K | 88.000 K | 169.000 K | 405.000 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 43.657 M | |
| Property Plant Equipment | 12.797 M | 15.420 M | 13.851 M | 6.567 M | 3.581 M | 2.349 M | |
| Other Assets | 32.190 M | 34.115 M | 35.722 M | 18.774 M | 13.889 M | 55.580 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 90.032 M | 93.678 M | 91.808 M | 50.111 M | 42.041 M | 65.702 M | |
| Total liabilities | 45.165 M | 49.602 M | 53.682 M | 34.993 M | 30.605 M | 58.841 M | |
| Total current liabilities | 23.907 M | 28.012 M | 28.698 M | 24.052 M | 25.626 M | 55.287 M | |
| Accounts Payable | 11.759 M | 13.628 M | 15.459 M | 13.326 M | 15.032 M | 41.848 M | |
| Other liabilities | 9.864 M | 10.369 M | 9.548 M | 8.368 M | 3.889 M | 2.965 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 10.294 M | 10.328 M | 14.508 M | 1.834 M | 436.000 K | 0.000 | |
| Other liabilities | 9.864 M | 10.369 M | 9.548 M | 8.368 M | 3.889 M | 2.965 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 44.867 M | 44.076 M | 38.126 M | 15.118 M | 11.436 M | 6.861 M | |
| Common stock | 120.301 M | 125.721 M | 126.357 M | 119.866 M | 120.174 M | 122.440 M | |
| Retained earnings | -11.294 M | -17.447 M | -24.034 M | -54.427 M | -58.899 M | -65.738 M |